Overstock.com, Inc. (OSTK) Analysts See $-0.09 EPS; Ziopharm Oncology (ZIOP) SI Decreased By 0.62%

October 13, 2017 - By Vivian Park

Ziopharm Oncology Incorporated (NASDAQ:ZIOP) had a decrease of 0.62% in short interest. ZIOP’s SI was 34.63 million shares in October as released by FINRA. Its down 0.62% from 34.84M shares previously. With 1.36 million avg volume, 26 days are for Ziopharm Oncology Incorporated (NASDAQ:ZIOP)’s short sellers to cover ZIOP’s short positions. The SI to Ziopharm Oncology Incorporated’s float is 32.4%. About 519,813 shares traded. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) has risen 1.75% since October 13, 2016 and is uptrending. It has underperformed by 14.95% the S&P500.

Analysts expect Overstock.com, Inc. (NASDAQ:OSTK) to report $-0.09 EPS on November, 2.They anticipate $0.03 EPS change or 25.00% from last quarter’s $-0.12 EPS. After having $-0.29 EPS previously, Overstock.com, Inc.’s analysts see -68.97% EPS growth. About 726,285 shares traded. Overstock.com, Inc. (NASDAQ:OSTK) has declined 7.99% since October 13, 2016 and is downtrending. It has underperformed by 24.69% the S&P500.

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The company has market cap of $794.99 million. The Firm is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies to deliver cell- and viral therapies for the treatment of cancer and graft-versus-host-disease. It currently has negative earnings. It has developed an adenoviral vector, Ad-RTS-IL-12, which is administered intra-tumorally under the control of the RheoSwitch Therapeutic System expression platform.

Among 4 analysts covering Ziopharm Oncology (NASDAQ:ZIOP), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Ziopharm Oncology had 6 analyst reports since December 4, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Mizuho on Monday, January 25. Wells Fargo initiated the stock with “Underperform” rating in Friday, December 4 report. The stock of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) earned “Market Perform” rating by Wells Fargo on Wednesday, August 10. Raymond James initiated ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) on Thursday, June 2 with “Market Perform” rating. Mizuho maintained the shares of ZIOP in report on Wednesday, May 11 with “Neutral” rating.

Investors sentiment decreased to 1.42 in 2017 Q2. Its down 0.66, from 2.08 in 2017Q1. It dropped, as 15 investors sold Overstock.com, Inc. shares while 18 reduced holdings. 14 funds opened positions while 33 raised stakes. 10.49 million shares or 1.95% more from 10.29 million shares in 2017Q1 were reported. Legal & General Gp Public Limited has 4,258 shares for 0% of their portfolio. 116,638 are owned by Cornerstone Capital Hldgs Ltd. Tiaa Cref Investment Limited Liability Corporation invested in 62,601 shares or 0% of the stock. Citigroup Incorporated accumulated 0% or 1,012 shares. Moreover, Northern Trust Corp has 0% invested in Overstock.com, Inc. (NASDAQ:OSTK) for 211,495 shares. 42,581 were accumulated by Wellington Mngmt Grp Inc Ltd Liability Partnership. Matarin Mgmt Ltd Liability Corp reported 105,566 shares or 0% of all its holdings. Portolan Capital Ltd Com invested in 0.29% or 136,722 shares. Vanguard Grp Inc Inc Inc invested 0% in Overstock.com, Inc. (NASDAQ:OSTK). Royal Bank & Trust Of Canada invested in 0% or 280 shares. Goldman Sachs Group Inc has invested 0% in Overstock.com, Inc. (NASDAQ:OSTK). Ny State Common Retirement Fund accumulated 26,394 shares. Morgan Stanley holds 0% or 92,229 shares. 1.58 million were reported by Dimensional Fund Advsrs Limited Partnership. Wolverine Asset Management Limited Co reported 0.01% of its portfolio in Overstock.com, Inc. (NASDAQ:OSTK).

Since May 1, 2017, it had 0 insider purchases, and 2 sales for $58,929 activity. The insider JOHNSON JONATHAN E III sold 500 shares worth $8,700. On Friday, May 26 the insider Popelka Brian L. sold $50,229.

Overstock.com, Inc. is an online retailer and incubator of blockchain technology. The company has market cap of $731.26 million. Through its online retail business, the Company offers a range of price-competitive brand name, non-brand name and closeout products, including furniture, home decor, bedding and bath, housewares, jewelry and watches, apparel and designer accessories, health and beauty products, electronics and computers, and sporting goods. It currently has negative earnings. It operates Retail and Medici businesses.

Among 2 analysts covering Overstock.com (NASDAQ:OSTK), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Overstock.com had 3 analyst reports since May 26, 2016 according to SRatingsIntel. The rating was maintained by Maxim Group with “Buy” on Wednesday, February 1. The stock of Overstock.com, Inc. (NASDAQ:OSTK) has “Buy” rating given on Thursday, May 26 by Maxim Group. The stock of Overstock.com, Inc. (NASDAQ:OSTK) has “Buy” rating given on Wednesday, September 6 by DA Davidson.